These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. The application of the CRISPR-Cas9 genome editing machinery in food and agricultural science: Current status, future perspectives, and associated challenges. Eş I; Gavahian M; Marti-Quijal FJ; Lorenzo JM; Mousavi Khaneghah A; Tsatsanis C; Kampranis SC; Barba FJ Biotechnol Adv; 2019; 37(3):410-421. PubMed ID: 30779952 [TBL] [Abstract][Full Text] [Related]
29. CRISPR/Cas9 technology as a potent molecular tool for gene therapy. Karimian A; Azizian K; Parsian H; Rafieian S; Shafiei-Irannejad V; Kheyrollah M; Yousefi M; Majidinia M; Yousefi B J Cell Physiol; 2019 Aug; 234(8):12267-12277. PubMed ID: 30697727 [TBL] [Abstract][Full Text] [Related]
30. Gene targeting technologies in rats: zinc finger nucleases, transcription activator-like effector nucleases, and clustered regularly interspaced short palindromic repeats. Mashimo T Dev Growth Differ; 2014 Jan; 56(1):46-52. PubMed ID: 24372523 [TBL] [Abstract][Full Text] [Related]
31. Genome editing technologies to fight infectious diseases. Trevisan M; Palù G; Barzon L Expert Rev Anti Infect Ther; 2017 Nov; 15(11):1001-1013. PubMed ID: 29090592 [TBL] [Abstract][Full Text] [Related]
32. Recent Advances in the Production of Genome-Edited Rats. Sato M; Nakamura S; Inada E; Takabayashi S Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269691 [TBL] [Abstract][Full Text] [Related]
33. Editing the genome of common cereals (Rice and Wheat): techniques, applications, and industrial aspects. Das N; Ghosh Dhar D; Dhar P Mol Biol Rep; 2023 Jan; 50(1):739-747. PubMed ID: 36309609 [TBL] [Abstract][Full Text] [Related]
34. Genome centric engineering using ZFNs, TALENs and CRISPR-Cas9 systems for trait improvement and disease control in Animals. Wani AK; Akhtar N; Singh R; Prakash A; Raza SHA; Cavalu S; Chopra C; Madkour M; Elolimy A; Hashem NM Vet Res Commun; 2023 Jan; 47(1):1-16. PubMed ID: 35781172 [TBL] [Abstract][Full Text] [Related]
35. Applications of Genome Editing Tools in Stem Cells Towards Regenerative Medicine: An Update. Kues WA; Kumar D; Selokar NL; Talluri TR Curr Stem Cell Res Ther; 2022; 17(3):267-279. PubMed ID: 34819011 [TBL] [Abstract][Full Text] [Related]
36. To CRISPR and beyond: the evolution of genome editing in stem cells. Chen KY; Knoepfler PS Regen Med; 2016 Dec; 11(8):801-816. PubMed ID: 27905217 [TBL] [Abstract][Full Text] [Related]
37. The genome editing revolution: A CRISPR-Cas TALE off-target story. Stella S; Montoya G Bioessays; 2016 Jul; 38 Suppl 1():S4-S13. PubMed ID: 27417121 [TBL] [Abstract][Full Text] [Related]
38. Target-specific gene delivery in plant systems and their expression: Insights into recent developments. Nandy D; Maity A; Mitra AK J Biosci; 2020; 45():. PubMed ID: 32020912 [TBL] [Abstract][Full Text] [Related]
39. In Vivo Genome Editing as a Therapeutic Approach. Ho BX; Loh SJH; Chan WK; Soh BS Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30213032 [TBL] [Abstract][Full Text] [Related]